← Leaderboards
Gregory Y Chang
University Of Southern California
$347,081
Attributed
$347,081
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$347,081 · 1
By mechanism
M01$347,081 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- David Ko$2,344,909
- Andrea A. Kovacs$11,647,115
- Christy Russell$719,837
- Derek Raghavan$1,863,220
- Heinz Josef Lenz$20,123,312
Others in their field
Top investigators on “Anticonvulsants”
- Jaideep Kapur · University Of Virginia$17,928,480
- Kevin J. Staley · University Of Colorado Denver$16,673,750
- Tracy A Glauser · Children'S Hospital Med Ctr (Cincinnati)$15,974,607
- Kimford J Meador · Medical College Of Georgia (Mcg)$13,834,484
- Doodipala Samba Reddy · North Carolina State University Raleigh$12,108,262
- James K Rowlett · Harvard University (Medical School)$10,943,405
Research focus
AnticonvulsantsCarbamazepineClinical ResearchCombination ChemotherapyDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationNervous System Disorder ChemotherapyNeurotransmitter TransportPartial SeizurePhenytoinTransport Inhibitor
Grant awards (5)
SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT$0
M01 · FY2002 · RR
SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT$155,764
M01 · FY2001 · RR
SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT$0
M01 · FY2001 · RR
SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT$155,764
M01 · FY2000 · RR
SAFETY AND EFFICACY OF TIAGABINE HCL AS ADJUNCTIVE TREATMENT$35,553
M01 · FY2000 · RR